Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code
x Close Forever Close
Volume 37 Issue 5
. 
Turn off MathJax
Article Contents
Abstract
References
Article Navigation >  Journal of Pharmaceutical Practice and Service  > 2019  >  37(5): 433-439

DING Huamin, GUO Yuchen, QIN Chunxia, SONG Zhibing, SUN Lili. Therapeutic effect of Xiaofeng Zhiyang granules on acute itching in mice with atopic dermatitis by decreasing leukotriene[J]. Journal of Pharmaceutical Practice and Service, 2024, 42(5): 211-216. doi: 10.12206/j.issn.2097-2024.202306031
Citation: ZHOU Jing, WU Gao, MA Fujia. Study on the mechanism of proliferation of human lung cancer A549 cells regulated by hsa-miRNA-30a-5p[J]. Journal of Pharmaceutical Practice and Service, 2019, 37(5): 433-439. doi: 10.3969/j.issn.1006-0111.2019.05.009
shu

Study on the mechanism of proliferation of human lung cancer A549 cells regulated by hsa-miRNA-30a-5p

doi: 10.3969/j.issn.1006-0111.2019.05.009
  • 1.

    Department of Pharmacy, Ningbo Women's and Children's Hospital, Ningbo, 315012, China

  • 2.

    Hongkou Branch, Changhai Hospital Affiliated to Naval Medical University, Shanghai, 200081, China

  • 3.

    Department of Pharmacy, Naval Special Medical Center, Shanghai 200052, China

  • Received Date: 2018-12-11
  • Rev Recd Date: 2019-04-03
  • Objective To study the regulation and mechanism of hsa-miRNA-30a-5p on the proliferation of human lung cancer A549 cells. Methods Five pairs of lung cancer and para-carcinoma tissues were harvested in clinical and measured for hsa-miRNA-30a-5p and SCARA5 levels by real-time PCR and western blotting,respectively.The theoretical binding site of hsa-miRNA-30a-5p in SCARA5's 3'UTR was predicted by bioinformatics,and validated by luciferase report assay.A549 cells were transfected with pshRNA-SCARA5 and miRNA-30a-5p inhibitor and 48 h later,the proliferation of A549 cells after genetic intervention was assayed by the MTT method,and the cell growth curve was plotted to observe the effect of hsa-miRNA-30a-5p knockdown on cell proliferation. Results For all five pairs of samples tested,hsa-miRNA-30a-5p was higher in the cancer tissues than in the adjacent tissue(P<0.05),and SCARA5 protein was lower in the cancer tissues than in the adjacent tissue (P<0.05).The bioinformatics analysis showed that there was a theoretical binding site of hsa-miRNA-30a-5p in SCARA5's 3'UTR.The luciferase assay showed that miRNA-30a mimics inhibited the luciferase expressed by the luciferase reporter vector carrying a wild-type SCARA5's 3'UTR(pGL3-WT- SCARA5)(P<0.05,vs pGL3-WT-SCARA5 alone),and miRNA-30a-5p inhibitor enhanced the luciferase activity(P<0.05,vs pGL3-WT- SCARA5 alone).No change was observed when miRNA-30a-5p mimics or miRNA-30a-5p inhibitor was co-transfected with the luciferase reporter vector carrying a mutant SCARA5's 3'UTR(pGL3-MT- SCARA5)(P>0.05,vs pGL3-WT- SCARA5 alone).Hsa-miRNA-30a-5p level in A549 cells transfected with miRNA-30a inhibitor for 48 h was significantly decreased(P<0.05,vs cell control or NC),and there was no difference in hsa-miRNA-30a-5p between the negative control and the transfection control(P>0.05).The proliferation of A549 cells was suppressed by transfection with miRNA-30a-5p inhibitor 24-72 h after transfection(P<0.05,vs control or NC). Conclusion Hsa-miRNA-30a-5p could increase the proliferation in A549 cells via suppressing the expression of SCARA5,and transfection of miRNA-30a-5p inhibitor could inhibit the proliferation of A549 cells via up-regulating SCARA5 expression.
  • [1] 陈万青,张思维,邹小农.中国肺癌发病死亡的估计和流行趋势研究[J].中国肺癌杂志,2010,13(5):488-493.
    [2] 李媛秋,代敏,陈元立,等.中国省区水平肺癌死亡率估计方法研究[J].中国肺癌杂志,2011,14(2):120-126.
    [3] BARTEL D P.MicroRNAs:genomics,biogenesis,mechanism,and function[J].Cell,2004,116(2):281-297.
    [4] ISSAC B,GALOIAN K,GUETTOUCHE T,et al.Genome-wide mRNA and miRNA expression data analysis to screen for markers involved in sarcomagenesis in human chondrosarcoma cell lines[J].Genom Data,2014,2:320-324.
    [5] MISHRA S,YADAV T,RANI V.Exploring miRNA based approaches in cancer diagnostics and therapeutics[J].Crit Rev Oncol Hematol,2016,98:12-23.
    [6] WINTHER M,ALSNER J,TRAMM T,et al.Evaluation of miR-21 and miR-375 as prognostic biomarkers in esophageal cancer[J].Acta Oncol,2015,54(9):1582-1591.
    [7] WANG P,GUO X Y,ZONG W,et al.MicroRNA-128b suppresses tumor growth and promotes apoptosis by targeting A2bR in gastric cancer[J].Biochem Biophys Res Commun,2015,467(4):798-804.
    [8] EGELAND N G,LUNDE S R,JONSDOTTIR K,et al.The role of microRNAs as predictors of response to tamoxifen treatment in breast cancer patients[J].Int J Mol Sci,2015,16(10):24243-24275.
    [9] LI L P,GUO Y,CHEN Y Z,et al.The diagnostic efficacy and biological effects of microRNA-29b for colon cancer[J].Technol Cancer Res Treat,2016,15(6):772-779.
    [10] KNUDSEN K N,NIELSEN B S,LINDEBJERG J,et al.MicroRNA-17 is the most up-regulated member of the mir-17-92 cluster during early colon cancer evolution[J].PLoS One,2015,10(10):e0140503.
    [11] I H,CHO J Y.Lung cancer biomarkers[J].Adv Clin Chem,2015,72:107-170.
    [12] CHEN Z Z,WU Y,MENG Q T,et al.Elevated microRNA-25 inhibits cell apoptosis in lung cancer by targeting RGS3[J].In Vitro Cell Dev Biol Anim,2016,52(1):62-67.
    [13] DONG W,YAO C P,TENG X P,et al.MiR-140-3p suppressed cell growth and invasion by downregulating the expression of ATP8A1 in non-small cell lung cancer[J].Tumour Biol,2016,37(3):2973-2985.
    [14] SONG L,LI D,ZHAO Y K,et al.MiR-218 suppressed the growth of lung carcinoma by reducing MEF2D expression[J].Tumour Biol,2016,37(3):2891-2900.
    [15] LIN L,LIN H B,WANG L,et al.MiR-130a regulates macrophage polarization and is associated with non-small cell lung cancer[J].Oncol Rep,2015,34(6):3088-3096.
    [16] SONG Y F,HONG J F,LIU D L,et al.MiR-630 targets LMO3 to regulate cell growth and metastasis in lung cancer[J].Am J Transl Res,2015,7(7):1271-1279.
    [17] MA R Q,WANG C Y,WANG J J,et al.MiRNA-mRNA interaction network in non-small cell lung cancer[J].Interdiscip Sci,2016,8(3):209-219.
    [18] HUANG J,ZHENG D L,QIN F S,et al.Genetic and epigenetic silencing of SCARA5 may contribute to human hepatocellular carcinoma by activating FAK signaling[J].J Clin Invest,2010,120(1):223-241.
    [19] KHAMAS A,ISHIKAWA T,SHIMOKAWA K,et al.Screening for epigenetically masked genes in colorectal cancer Using 5-Aza-2'-deoxycytidine,microarray and gene expression profile[J].Cancer Genom Proteomics,2012,9(2):67-75.
    [20] YAN N,ZHANG S,YANG Y,et al.Therapeutic upregulation of class A scavenger receptor member 5 inhibits tumor growth and metastasis[J].Cancer Sci,2012,103(9):1631-1639.
    [21] LIU J,HU G,CHEN D,et al.Suppression of SCARA5 by Snail1 is essential for EMT-associated cell migration of A549 cells[J].Oncogenesis,2013,2:e73.
    [22] WEI W,YANG Y,CAI J,et al.MiR-30a-5p suppresses tumor metastasis of human colorectal cancer by targeting ITGB3[J].Cell Physiol Biochem,2016,39(3):1165-1176.
    [23] BARANISKIN A,BIRKENKAMP-DEMTRODER K,MAGHNOUJ A,et al.MiR-30a-5p suppresses tumor growth in colon carcinoma by targeting DTL[J].Carcinogenesis,2012,33(4):732-739.
    [24] FRANZETTI G A,LAUD-DUVAL K,BELLANGER D,et al.MiR-30a-5p connects EWS-FLI1 and CD99,two major therapeutic targets in Ewing tumor[J].Oncogene,2013,32(33):3915-3921.
  • Created with Highcharts 5.0.7Amount of accessChart context menuAbstract Views, HTML Views, PDF Downloads StatisticsAbstract ViewsHTML ViewsPDF Downloads2024-052024-062024-072024-082024-092024-102024-112024-122025-012025-022025-032025-040Highcharts.com
    Created with Highcharts 5.0.7Chart context menuAccess Class DistributionFULLTEXT: 91.5 %FULLTEXT: 91.5 %META: 7.7 %META: 7.7 %PDF: 0.8 %PDF: 0.8 %FULLTEXTMETAPDFHighcharts.com
    Created with Highcharts 5.0.7Chart context menuAccess Area Distribution其他: 26.2 %其他: 26.2 %China: 0.6 %China: 0.6 %United States: 0.2 %United States: 0.2 %三明: 0.4 %三明: 0.4 %上海: 1.0 %上海: 1.0 %中卫: 0.2 %中卫: 0.2 %临汾: 0.2 %临汾: 0.2 %丹东: 0.2 %丹东: 0.2 %保定: 0.2 %保定: 0.2 %北京: 18.5 %北京: 18.5 %呼和浩特: 0.2 %呼和浩特: 0.2 %宁波: 0.4 %宁波: 0.4 %宣城: 0.2 %宣城: 0.2 %常州: 0.2 %常州: 0.2 %广州: 0.2 %广州: 0.2 %廊坊: 0.4 %廊坊: 0.4 %张家口: 0.8 %张家口: 0.8 %张掖: 0.2 %张掖: 0.2 %德州: 0.2 %德州: 0.2 %成都: 1.2 %成都: 1.2 %昆明: 0.4 %昆明: 0.4 %普洱: 0.2 %普洱: 0.2 %杭州: 0.6 %杭州: 0.6 %武汉: 0.4 %武汉: 0.4 %沈阳: 0.2 %沈阳: 0.2 %洛阳: 0.2 %洛阳: 0.2 %济宁: 0.2 %济宁: 0.2 %湖州: 0.2 %湖州: 0.2 %漳州: 0.4 %漳州: 0.4 %潍坊: 0.2 %潍坊: 0.2 %盐城: 0.2 %盐城: 0.2 %石家庄: 1.4 %石家庄: 1.4 %福州: 0.2 %福州: 0.2 %芒廷维尤: 20.5 %芒廷维尤: 20.5 %西宁: 20.9 %西宁: 20.9 %西安: 0.2 %西安: 0.2 %运城: 0.4 %运城: 0.4 %长治: 0.2 %长治: 0.2 %黄冈: 0.8 %黄冈: 0.8 %龙岩: 0.2 %龙岩: 0.2 %其他ChinaUnited States三明上海中卫临汾丹东保定北京呼和浩特宁波宣城常州广州廊坊张家口张掖德州成都昆明普洱杭州武汉沈阳洛阳济宁湖州漳州潍坊盐城石家庄福州芒廷维尤西宁西安运城长治黄冈龙岩Highcharts.com

  • Cited by

    Periodical cited type(10)

    1. 严莹莹，王曼莉，李锦鸿，李承龙，洪光博，黄丽平. 石菖蒲中β-细辛醚的提取工艺优化及其体外抗氧化活性研究. 中国现代应用药学. 2024(01): 18-26 .
    2. 孙洁颖，米宝丽，郭芮嘉，王晓，赵楠，刘威. 基于正交实验和Box-Behnken 响应面法优选白芨多糖提取工艺. 广州化工. 2024(05): 116-120 .
    3. 周晓丹，赵文静，吴汐柔，邹婕，李鹏晨，汪梦杰，李曹龙. 响应面法优化蛹虫草多糖提取工艺研究. 广州化工. 2024(13): 17-20 .
    4. 石震方，伏小刚，高富成，徐垒，李建设，叶林. 基于响应曲面法的露地甘蓝移栽效率优化研究. 南方农机. 2024(24): 1-6 .
    5. 柯翠敏，李丝红，胡建萍，谢志新. 运用响应面分析法优化鬼针草总黄酮的提取工艺. 继续医学教育. 2022(03): 109-112 .
    6. 邱宏聪，刘布鸣，张华，马军花，吴文华. 复方金钱草颗粒的二次开发研究进展. 广西科学. 2022(01): 45-51 .
    7. 杨佳力，陈俊沲，华丽萍，张双双，徐珏雯，石森林. 正交设计与Box-Behnken响应面法优化逍遥散的制备工艺. 华西药学杂志. 2022(03): 285-291 .
    8. 解杨，钟凌云，薛晓，王卓，宋金菊，李家晴，张青，王毅彬，曾妍. 基于多指标-响应曲面法优选炆地黄炮制工艺及成分与色泽相关性分析. 中国中药杂志. 2022(18): 4927-4937 .
    9. 徐敬朴，李德强，郑丽亚，程新杰，卞广丽. 响应面法优化积雪草的微波提取工艺. 西北药学杂志. 2021(01): 1-5 .
    10. 郝明洁，胡德栋，陈晓娜. 撞击流环隙喷嘴在超临界流体技术制备药物超微颗粒中的应用研究. 能源化工. 2020(04): 45-50 .

    Other cited types(7)

通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索
Get Citation
PDF
XML

Article Metrics

Article views(4588) PDF downloads(315) Cited by(17)

Related
Proportional views

Study on the mechanism of proliferation of human lung cancer A549 cells regulated by hsa-miRNA-30a-5p

doi: 10.3969/j.issn.1006-0111.2019.05.009
  • 1. Department of Pharmacy, Ningbo Women's and Children's Hospital, Ningbo, 315012, China
  • 2. Hongkou Branch, Changhai Hospital Affiliated to Naval Medical University, Shanghai, 200081, China
  • 3. Department of Pharmacy, Naval Special Medical Center, Shanghai 200052, China
  • Received Date: 2018-12-11
  • Rev Recd Date: 2019-04-03

Abstract: Objective To study the regulation and mechanism of hsa-miRNA-30a-5p on the proliferation of human lung cancer A549 cells. Methods Five pairs of lung cancer and para-carcinoma tissues were harvested in clinical and measured for hsa-miRNA-30a-5p and SCARA5 levels by real-time PCR and western blotting,respectively.The theoretical binding site of hsa-miRNA-30a-5p in SCARA5's 3'UTR was predicted by bioinformatics,and validated by luciferase report assay.A549 cells were transfected with pshRNA-SCARA5 and miRNA-30a-5p inhibitor and 48 h later,the proliferation of A549 cells after genetic intervention was assayed by the MTT method,and the cell growth curve was plotted to observe the effect of hsa-miRNA-30a-5p knockdown on cell proliferation. Results For all five pairs of samples tested,hsa-miRNA-30a-5p was higher in the cancer tissues than in the adjacent tissue(P<0.05),and SCARA5 protein was lower in the cancer tissues than in the adjacent tissue (P<0.05).The bioinformatics analysis showed that there was a theoretical binding site of hsa-miRNA-30a-5p in SCARA5's 3'UTR.The luciferase assay showed that miRNA-30a mimics inhibited the luciferase expressed by the luciferase reporter vector carrying a wild-type SCARA5's 3'UTR(pGL3-WT- SCARA5)(P<0.05,vs pGL3-WT-SCARA5 alone),and miRNA-30a-5p inhibitor enhanced the luciferase activity(P<0.05,vs pGL3-WT- SCARA5 alone).No change was observed when miRNA-30a-5p mimics or miRNA-30a-5p inhibitor was co-transfected with the luciferase reporter vector carrying a mutant SCARA5's 3'UTR(pGL3-MT- SCARA5)(P>0.05,vs pGL3-WT- SCARA5 alone).Hsa-miRNA-30a-5p level in A549 cells transfected with miRNA-30a inhibitor for 48 h was significantly decreased(P<0.05,vs cell control or NC),and there was no difference in hsa-miRNA-30a-5p between the negative control and the transfection control(P>0.05).The proliferation of A549 cells was suppressed by transfection with miRNA-30a-5p inhibitor 24-72 h after transfection(P<0.05,vs control or NC). Conclusion Hsa-miRNA-30a-5p could increase the proliferation in A549 cells via suppressing the expression of SCARA5,and transfection of miRNA-30a-5p inhibitor could inhibit the proliferation of A549 cells via up-regulating SCARA5 expression.

DING Huamin, GUO Yuchen, QIN Chunxia, SONG Zhibing, SUN Lili. Therapeutic effect of Xiaofeng Zhiyang granules on acute itching in mice with atopic dermatitis by decreasing leukotriene[J]. Journal of Pharmaceutical Practice and Service, 2024, 42(5): 211-216. doi: 10.12206/j.issn.2097-2024.202306031
Citation: ZHOU Jing, WU Gao, MA Fujia. Study on the mechanism of proliferation of human lung cancer A549 cells regulated by hsa-miRNA-30a-5p[J]. Journal of Pharmaceutical Practice and Service, 2019, 37(5): 433-439. doi: 10.3969/j.issn.1006-0111.2019.05.009
shu

    HTML

Reference (24)

Catalog

  • HTML

版权所有：《药学实践与服务》编辑委员会

Supervisor & Sponsors: Address: No 325 Guohe Road, ShanghaiPost Code: 200433

Tel: （021）81871324,81871397 E-mail: yxsjzzs@163.com

网站备案号 沪ICP备05003363号-1

Supported by: Beijing Renhe Information Technology Co., Ltd.  

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return